Biotech Values

[dewophile]

as worstluck pointed out i am the tourist take, and he or she is probably correct - i mean i saw the other rescue criteria for eypt but i didnt bother to dive in, but the letter loss was different, so my point is that it might be a bit comparing apples and oranges and maybe eypt is looser, maybe it is not, but if looser then ocul rescue free would be lower not higher as those with 11-14 letter loss would be rescued under eypt criteria and not ocul
the resident expert here posted that eypt is clearly worse than ocul, and based on later time points past 24 weeks that seems clear, but at 24 weeks given diffeences in rescue criteria am i 100% certain this is the case? eypt is ahead in the NI trial, and there is no way ocul gets approval without successful sol-r IMO despite what they say about filing just based on sol-1
so maybe you can handicap sol-r better than I, but right now I cannot
and DD did point out that there is the issue of safety and long term safety, and I pointed out the pain and risk w needle size injection, so you have to decisively beat eylea HD or vabysmo. I think very good 6mo dosing with flexibility up to 1 year does that
I think i am done now